Meghan Mullooly brings over 15 years of expertise in specialty pharmaceutical commercialization, with a focus on Patient Services. She expertly translates strategy into impact, working with manufacturers to design, build, and optimize solutions that drive operational excellence and meaningful patient outcomes.

Throughout her career, Meghan has developed deep expertise in translating strategic vision into tactical reality. At Neovance (formerly Covance), she spent over nine years in progressive roles, from business development and reimbursement strategy to leading teams of 300+. Her approach is grounded in understanding what is needed to get the work done well, then bringing industry-leading solutions and functional knowledge together to identify the right path forward.